Literature DB >> 21444029

Myeloproliferative disorders in pregnancy.

Claire N Harrison1, Susan E Robinson.   

Abstract

This article reviews pregnancy outcome in women diagnosed with a myeloproliferative neoplasm (MPN), and discusses possible risk markers and the pathogenesis of poor pregnancy outcome. An outline of the key factors regarding the diagnosis and management of MPN in women of reproductive potential is followed by a description of the authors' management strategy for standard and high-risk pregnancy in MPN patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21444029     DOI: 10.1016/j.hoc.2011.01.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

Review 1.  Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults.

Authors:  Nicole Kucine
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

2.  Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Authors:  M B Agarwal; Hemant Malhotra; Prantar Chakrabarti; Neelam Varma; Vikram Mathews; Jina Bhattacharyya; Tulika Seth; K Gayathri; Hari Menon; P G Subramanian; Ajay Sharma; Maitreyee Bhattacharyya; Jay Mehta; A K Vaid; Sandeep Shah; Shyam Aggarwal; P K Gogoi; Reena Nair; Usha Agarwal; Subhash Varma; S V S S Prasad; Marie Therese Manipadam
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jan-Mar

Review 3.  Hematologic malignancies during pregnancy: A review.

Authors:  Hossam K Mahmoud; Mohamed A Samra; Gamal M Fathy
Journal:  J Adv Res       Date:  2016-02-08       Impact factor: 10.479

4.  A case of Philadelphia chromosome positive myeloproliferative neoplasm in a pregnant woman with unusual primary myelofibrosis features.

Authors:  Jason Koshy; Jack Alperin; Bagi Jana; Avi Markowitz; You-Wen Qian
Journal:  Case Rep Hematol       Date:  2013-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.